Raia Drogasil (OTCMKTS:RADLY) Shares Gap Down – What’s Next?

Raia Drogasil S.A. (OTCMKTS:RADLY)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $3.9660, but opened at $3.7930. Raia Drogasil shares last traded at $3.7930, with a volume of 1,173,000 shares.

Analyst Ratings Changes

Separately, Zacks Research upgraded Raia Drogasil to a “hold” rating in a research note on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Raia Drogasil has a consensus rating of “Hold”.

Raia Drogasil Stock Performance

The company’s fifty day moving average is $3.57 and its 200-day moving average is $4.22.

Raia Drogasil (OTCMKTS:RADLY) last announced its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05. The firm had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.32 billion. On average, analysts anticipate that Raia Drogasil S.A. will post 0.16 earnings per share for the current year.

Raia Drogasil Company Profile

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.